DEPRESSION

DEPRESSION:

• 2024
• Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy. https://pubmed.ncbi.nlm.nih.gov/38796933/ 
• Cannabinoids in the treatment of selected mental illnesses: practical approach and overview of the literature. https://www.thieme-connect.de/products/ejournals/html/10.1055/a-2256-0098 
• Effectiveness of Medical Cannabis for the treatment of Depression: A naturalistic outpatient study. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2215-6114 
• 2023
• Cross-disorder GWAS meta analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder and schizophrenia. https://pubmed.ncbi.nlm.nih.gov/37924773/ 
• Physician-Guided medical cannabis treatment for co-morbid anxiety and depression disorders in a Canadian Multidisciplinary clinic: A retrospective review. https://www.endocannabinoidmedicine.com/academicarticle/physician-guided-medical-cannabis-treatment-for-comorbid-anxiety-and-depression-disorders-in-a-canadian-multidisciplinary-clinic-a-retrospective-review/ 
• Psilocybin shows promising and sustained antidepressant effects in patients with Major Depressive Disorder. https://www.endocannabinoidmedicine.com/news/psilocybin-shows-promising-and-sustained-antidepressant-effects-in-patients-with-major-depressive-disorder/
• Psilocybin, an effective treatment for major depressive disorder in Adults - a systematic review. https://www.cpn.or.kr/journal/view.html?uid=1577&vmd=Full& 
• Possible Effects of the Endocannabinoid system on the Pathophysiology of depression: Medical Treatment approached based on this system. https://cms.turkmedstudj.com/Uploads/Article_60707/tmsj-10-86-En.pdf 
• Under the umbrella of depression and Alzheimer's disease pathophysiology: Can cannabinoids be a Dual pleiotropic therapy? https://www.sciencedirect.com/science/article/pii/S1568163723001575 
• Best marijuana strains for depression: https://cannigma.com/strain/best-marijuana-strains-for-depression/?utm_source=The%20Cannigma%20B2B&utm_medium=email&utm_campaign=Newsletter%2016.05.23%20%2801H0CN6Y1H4AMHXCT1KMYNCMFG%29&_kx=_uv58WsEi9s6bfI1NDeC26zVRyr2jgRfDXqxHEq9LD4%3D.J8JtEm
• Assessment of Clinical Outcomes of medicinal cannabis therapy for depression: analysis from the UK medical Cannabis Registry. https://pubmed.ncbi.nlm.nih.gov/36573268/
• Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A case series: (USA, Abstract, 2019) https://www.liebertpub.com/doi/full/10.1089/acm.2018.0437 
• The therapeutic role of Cannabidiol in mental health: a systematic review:  https://link.springer.com/article/10.1186/s42238-019-0012-y#Sec15
• Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians    https://journals.sagepub.com/doi/full/10.1177/0269881119882806
• Cannabis could help alleviate depression and suicidality among people with PTSD:  https://www.med.ubc.ca/news/cannabis-could-help-alleviate-depression-and-suicidality-among-people-with-ptsd/
• Cannabis shows potential for treating PTSD: New study: https://www.toronto.com/opinion-story/9681557-cannabis-shows-potential-for-treating-ptsd-new-study/
• 2020
• Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. (Australia/ UK, full, 2020) https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-019-2409-8 
• Experiencing sexual harassment by males and associated substance use & poor mental health outcomes among adolescent girls in the US. (USA, full, 2020) https://www.sciencedirect.com/science/article/pii/S2352827318302842?via%3Dihub 
• Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats. (USA/ India, full, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0022395619307356?via%3Dihub 
• Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand. (New Zealand, link to PDF, 2020) https://www.researchgate.net/publication/339046590_Cannabidiol_prescription_in_clinical_practice_an_audit_on_the_first_400_patients_in_New_Zealand 
• Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression. (Republic of Korea, abstract, 2020) https://www.sciencedirect.com/science/article/pii/S0166432819313348?via%3Dihub 
• Depressive symptoms moderate cannabis use for young adults in a Text-Delivered randomized clinical trial for cannabis use disorder. (USA, abstract, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0306460319313279?via%3Dihub 
• Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012-2017. (USA, abstract, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0376871620300326 
• Negative mood as a mediator of the association between insomnia severity and marijuana problems in college students. (USA, abstract, 2020) https://pubmed.ncbi.nlm.nih.gov/31997499/ 
• Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats. (Italy, abstract, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0924977X20300018 
• Dietary intake of polyunsaturated fatty acids alleviates cognition deficits and depression-like behaviour via cannabinoid system in sleep deprivation rats. (China, abstract, 2020) https://www.sciencedirect.com/science/article/pii/S0166432819317218 
• 2019
• New link between endocannabinoids and exercise may help in treatment of depression.
  (news/ abst – 2019) https://neurosciencenews.com/depression-exercise-endocannabinoids-14714/
• Medical marijuana can help your stress-induced depression. (news – 2019)
  https://www.thegrowthop.com/cannabis-health/medical-marijuana-can-help-your-stress-induced-depression
• Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients. (Australia, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337866/ 
• Characterizing chronic pain in late adolescence and early adulthood: prescription opioids, marijuana use, obesity, and predictors for greater pain interference. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344139/ 
• From Substance Use Disorders in Life to Autopsy Findings: A Combined Case-Record and Medico-Legal Study. (Sweden, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427694/ 
• Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms. (USA/ Canada, full, 2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0658?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed& 
• Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines. (Venezuela/ Colombia/ USA, full, 2019) https://www.hindawi.com/journals/aps/2019/7943481/ 
• Cannabis and Mood Disorders. (USA/ Canada, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329464/ 
• Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis. (Austria, full, 2019) https://www.sciencedirect.com/science/article/pii/S0098299718300748?via%3Dihub 
• Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice. (Poland, full, 2019) https://www.sciencedirect.com/science/article/pii/S0091305719304873?via%3Dihub 
• A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2016- 2017. (USA, full, 2019) https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2751558 
• Management of chronic pain with Jalaprakshalana (water-wash) Shodhita (processed) Bhanga (Cannabis sativa L.) in cancer patients with deprived quality of life: An openlabel single arm clinical trial. (Jalaprakshalana = water curing until water is clear.- GSC) (India, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891996/ 
• Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933749/ 
• Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727944/ 
• Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report. (Canada, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944157/ 
• Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry. (Italy/ Greece, full, 2019) https://www.hindawi.com/journals/ecam/2019/2509129/ 
• The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review. (USA, link to PDF, 2019) https://www.researchgate.net/publication/333265797_The_Potential_Benefits_of_Palmitoylethanolamide_in_Palliation_A_Qualitative_Systematic_Review 
• Brain region-dependent changes in the expression of endocannabinoid-metabolizing enzymes in rats following antidepressant drugs. (Poland, link to PDF, 2019) https://www.researchgate.net/publication/338298063_Brain_region-dependent_changes_in_the_expression_of_endocannabinoid-metabolizing_enzymes_in_rats_following_antidepressant_drugs 
• Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care. (USA, download, 2019) https://www.cannabisskunksense.co.uk/uploads/site-files/Relationship_of_cannabis_use.pdf 
• Effects of cannabidiol in males and females in two different rat models of depression. (Israel/ USA, click “researchgate” for download, 2019) https://scholar.google.com/scholar?q=%22Effects+of+cannabidiol+in+males+and+females+in+two+different+rat+models+of+depression%22&hl=en&as_sdt=0&as_vis=1&oi=scholart 
• Stimulation of Peroxisome Proliferator-Activated Receptor-α by NPalmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior. (USA, click “researchgate” for download, 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Stimulation+of+Peroxisome+Proliferator-Activated+Receptor-%CE%B1+by+N-Palmitoylethanolamine+Engages+Allopregnanolone+Biosynthesis+to+Modulate+Emotional+Behavior.%22&btnG 
• A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, Canada. (Canada/ USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0165032718319293?via%3Dihub 
• Depressive Symptoms and Suicidality in Adolescents Using e-Cigarettes and Marijuana: A Secondary Data Analysis From the Youth Risk Behavior Survey. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30688723/ 
• Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment. (Iran, abstract, 2019) https://www.sciencedirect.com/science/article/pii/S0166432818316735?via%3Dihub 
• The association between substance use and depressive symptomatology in nursing university students in Mexico. (Mexico/ USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S1471595317306777?via%3Dihub 
• Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. (Brazil/Denmark, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0891061818302114?via%3Dihub 
• Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. (USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0277953619303272?via%3Dihub 
• MEDICAL MARIJUANA DEPENDENCE AMONG CHRONIC PAIN PATIENTS SUFFERING FROM DEPRESSION AND ANXIETY. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31339242/ 
• Association between history of concussion and substance use is mediated by mood disorders. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31359826/ 
• A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes. (Hungary/ UK, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0165032719303623?via%3Dihub 
• Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling. (China, abstract, 2019) https://www.sciencedirect.com/science/article/pii/S0091305719301376?via%3Dihub 
• Anhedonia in depression symptomatology: Appetite dysregulation and defective brain reward processing. (Italy, abstract, 2019) https://www.sciencedirect.com/science/article/pii/S0166432819303225?via%3Dihub 
• Cannabidiol (CBD) use in psychiatric disorders: A systematic review. (UK/ Italy, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0161813X19300774?via%3Dihub 
• Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants. (Spain, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0028390819300590 
• The "entourage effect": Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31481004/ 
• Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-α mouse model of depression. (Ireland, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0889159119306063?via%3Dihub 
• An overview of the heterogeneity of major depressive disorder: Current knowledge and Future prospective. (India, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31573890/ 
• Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain. (Poland, abstract, 2019) https://www.semanticscholar.org/paper/Role-of-endocannabinoid-system-in-dopamine-within-Mlost-W%C4%85sik/8ead21c33539fa530f887472c42bec2c88969902 
• N-Palmitoylethanolamide Exerts Antidepressant-Like Effects in Rats: Involvement of PPARα Pathway in the Hippocampus. (China, abstract, 2019) https://jpet.aspetjournals.org/content/369/1/163.long 
• Nutrition and immunology in mental health: Precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments. (UK/ Taiwan, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0889159119312322?via%3Dihub 
• Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on “Translational and Neuroscience Studies in Affective Disorders”. (Italy/ Canada, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0165032718315994?via%3Dihub 
• Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD. (Israel/ USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31622603/ 
• Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice. (Poland, abstract, 2019) https://www.sciencedirect.com/science/article/pii/S0166432819311891?via%3Dihub 
• Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users. (Canada, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0022395618304783 
• Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians. (Canada/ USA, abstract, 2019) https://journals.sagepub.com/doi/abs/10.1177/0269881119882806?journalCode=jopa& 
• Perceived Efficacy of Medical Cannabis in the Treatment of Co-Occurring HealthRelated Quality of Life Symptoms. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31693457/ 
• Potential new therapies against a toxic relationship: neuroinflammation and Parkinson's disease. (Brazil / Spain, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31703030/ 
• Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31712969/ 
• Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse. (Canada, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31725152/ 
• The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: A meta-analysis. (China, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31725603/ 
• Psychological and endocannabinoid responses to aerobic exercise in substance use disorder patients. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31729933/ 
• Link between personality and response to THC exposure. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31734264/ 
• Adverse childhood experience patterns, major depressive disorder, and substance use disorder in older adults. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31769297/ 
• Rapid increase in the prevalence of cannabis use among persons with depression in the U.S., 2005-2017: the role of differentially changing risk perceptions. (USA, abstract, 2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14883 
• 2018
• Medicinal cannabis use can help mitigate symptoms of PTSD, study says. (news – 2018)
  https://www.theglobeandmail.com/canada/article-medicinal-cannabis-use-can-help-mitigate-symptoms-of-ptsd-study-says/
• Veterans are left out of medical marijuana protections. (news – 2018)
  https://thehill.com/opinion/healthcare/394083-veterans-are-left-out-of-medical-marijuana-protections
• When It Comes to Medical Marijuana, Veterans Often Have to Improvise. (news – 2018)
  https://www.military.com/daily-news/2018/09/02/when-it-comes-medical-marijuana-veterans-often-have-improvise.html
• Use of Protective Behavioral Strategies among Young Adult Veteran Marijuana Users. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947861/ 
• Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. (Canada/ USA, full, 2018) https://link.springer.com/article/10.1186/s10194-018-0862-2 
• Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene (CNR1) and Personality in African-American Population. (USA/ China, full, 2018) https://www.frontiersin.org/articles/10.3389/fgene.2018.00199/full 
• Negative urgency partially accounts for the relationship between major depressive disorder and marijuana problems. (USA, full, 2018) https://bpded.biomedcentral.com/articles/10.1186/s40479-018-0087-7 
• Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users. (Australia, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908414/ 
• A naturalistic examination of the perceived effects of cannabis on negative affect. (USA, full, 2018) https://www.sciencedirect.com/science/article/pii/S0165032718303100 
• A Cross-Sectional Study of Cannabidiol Users. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/ 
• Cognitive and Mental Health Predictors of Withdrawal Severity During an Active Attempt to Cut Down Cannabis Use. (Netherlands, full, 2018) https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00301/full 
• An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. (Italy, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871676/ 
• The Consumption of Cannabis by Fibromyalgia Patients in Israel. (Israel, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081591/ 
• New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. (Italy/ USA, full, 2018) https://www.mdpi.com/2305-6320/5/4/107/htm 
• Evaluating the Long-Term Effectiveness of School-Based Depression, Anxiety, and Substance Use Prevention Into Young Adulthood: Protocol for the Climate School Combined Study. (Australia, full, 2018) https://www.researchprotocols.org/2018/11/e11372/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+ResProtoc+%28JMIR+Research+Protocols%29 
• Mental Health Issues and Substance Use in the United States: Pulling the Power Levers. (USA, full, 2018) https://pubmed.ncbi.nlm.nih.gov/30406713/ 
• Transcriptomic Characterization of the Human Habenula Highlights Drug Metabolism and the Neuroimmune System. (Canada/ USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220030/ 
• Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression. (Italy, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256035/ 
• Marijuana Use and Depressive Symptoms; Gender Differences in African American Adolescents. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250838/ 
• Adult cellular neuroadaptations induced by adolescent THC exposure in female rats are rescued by enhancing anandamide signaling. (Italy, full, 2018) https://academic.oup.com/ijnp/article/21/11/1014/5047132 
• Medicinal versus Recreational Cannabis Use among Returning Veterans. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037171/ 
• Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex. (Italy, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837889/ 
• Substance Use and Suicide in Pacific Islander, American Indian, and Multiracial Youth. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706273/ 
• The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082384/ 
• The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years. (Canada, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591882/ 
• Supporting Transgender and Gender Diverse Youth: Protection Against Emotional Distress and Substance Use. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501838/ 
• Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD. (Israel, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294292/ 
• Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202263/ 
• Itch and psyche: psychiatric aspects of pruritus. (USA, full, 2018) https://onlinelibrary.wiley.com/doi/full/10.1111/ijd.14081 
• Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157909/ 
• Sex Differences in the Association Between Cannabis Use and Suicidal Ideation and Attempts, Depression, and Psychological Distress Among Canadians. (Canada, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591888/ 
• Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476562/ 
• Integrating endocannabinoid signaling in the regulation of anxiety and depression. (China/ Canada, full, 2018) https://www.nature.com/articles/s41401-018-0051-5 
• Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects. (Italy, link to full, 2018) https://www.hindawi.com/journals/ecam/2018/1709182/ 
• Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities. (USA/ India/ Brazil, link to PDF, 2018) https://www.researchgate.net/publication/322709612_Prospects_of_Cannabidiol_for_Easing_Status_Epilepticus-Induced_Epileptogenesis_and_Related_Comorbidities 
• Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels. (Brazil, link to PDF, 2018) https://www.researchgate.net/publication/325611730_Antidepressant-like_effect_induced_by_Cannabidiol_is_dependent_on_brain_serotonin_levels 
• Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study. (USA, link to PDF, 2018) https://www.researchgate.net/publication/324093683_Marijuana_use_during_and_after_pregnancy_and_association_of_prenatal_use_on_birth_outcomes_A_population-based_study 
• Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores. (Spain, link to PDF, 2018) https://www.semanticscholar.org/paper/Associations-between-Polygenic-Risk-for-Psychiatric-Carey-Agrawal/7efd0879f4a8da6a6043f52cdf2dcb1dbe4958b7 
• Trajectories of alcohol and marijuana use among primary versus secondary psychopathy variants within an adjudicated adolescent male sample. (USA, link to PDF, 2018) https://www.researchgate.net/publication/326856425_Trajectories_of_Alcohol_and_Marijuana_Use_Among_Primary_Versus_Secondary_Psychopathy_Variants_Within_an_Adjudicated_Adolescent_Male_Sample 
• Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies. (Canada/ Israel, link to PDF, 2018) https://www.researchgate.net/publication/325589498_Association_of_Cannabis_With_Long-Term_Clinical_Symptoms_in_Anxiety_and_Mood_Disorders_A_Systematic_Review_of_Prospective_Studies 
• The endocannabinoid system in mental disorders: Evidence from human brain studies. (Spain, link to PDF, 2018) https://www.researchgate.net/publication/326451892_The_endocannabinoid_system_in_mental_disorders_Evidence_from_human_brain_studies 
• Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice. (Poland, link to download, 2018) https://isiarticles.com/bundles/Article/pre/pdf/154964.pdf 
• Developmental pathways of adolescent cannabis use: Risk factors, outcomes and sex-specific differences. (USA, click “researchgate” for download, 2018) https://www.researchgate.net/publication/328767762_Developmental_pathways_of_adolescent_cannabis_use_Risk_factors_outcomes_and_sex-specific_differences 
• Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex. (Spain, click “upf” for download, 2018) https://repositori.upf.edu/bitstream/handle/10230/35712/portero-ene-mate.pdf?sequence=1&isAllowed=y 
• Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: findings from 40 years of follow-up. (UK, full, 2018) https://eprints.kingston.ac.uk/id/eprint/40172/1/Theobald-D-40172-AAM.pdf 
• Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex. (Brazil/ Denmark, full, 2018) https://www.drperlmutter.com/wp-content/uploads/2018/12/CBD-BDNF.pdf 
• CB1 cannabinoid receptor ligands augment the antidepressant-like activity of biometals (magnesium and zinc) in the behavioural tests. (Poland, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/29380383/ 
• Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats. (Italy, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0028390818300510 
• Functional effects of synthetic cannabinoids versus Δ9 -THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression. (Israel, abstract, 2018) https://www.semanticscholar.org/paper/Functional-effects-of-synthetic-cannabinoids-versus-Schreiber-Bader/bdcc732eca01fb98bf65981d65180ad3c9839dd5 
• Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review. (Spain/ USA, abstract, 2018) https://www.semanticscholar.org/paper/Cannabinoid-Receptors%2C-Mental-Pain-and-Suicidal-a-Colino-Herranz-Herrer/aa390e07cd21931ef32b3b141ae8b22a8a50e400 
• Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. (Germany, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/29546791/ 
• The association between lifetime cannabis use and dysthymia across six birth decades. (Israel/ Canada/ USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0165032717324369 
• Circulating endocannabinoids and affect regulation in human subjects. (USA/ Canada, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306453017315470 
• Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain. (China, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/29863609/ 
• The relationship of endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia – a case control study. (Sweden, abstract, 2018) https://www.jpain.org/article/S1526-5900(18)30197-4/fulltext 
• Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats. (China, abstract, 2018) https://link.springer.com/article/10.1007/s11064-018-2591-y 
• Orbitofrontal connectivity is associated with depression and anxiety in marijuana-using adolescents. (USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0165032718300557 
• Cannabinoids in depressive disorders. (Poland, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0024320518306040?via%3Dihub 
• Interrelationships among depression, anxiety, flourishing, and cannabis use in youth. (Canada, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318304301 
• Predictors of drug use during pregnancy: The relative effects of socioeconomic, demographic, and mental health risk factors. (Canada, abstract, 2018) https://content.iospress.com/articles/journal-of-neonatal-perinatal-medicine/npm1814 
• 2017
• 10 Types of Marijuana That’ll Make You More Optimistic (news–2017) https://thefreshtoast.com/cannabis/10-types-of-marijuana-thatll-make-you-more-optimistic/#sthash.Dn5m1bN9.dpuf
• A Veteran Returned Home With PTSD And Pain, So He Became A Medical Marijuana Patient (news–2017) http://www.huffingtonpost.com/entry/leo-bridgewater-medical-marijuana-vets-ptsd_us_58fe630fe4b018a9ce5dd083
• CBD Oil Actually Helped With My Anxiety (news–2017) http://nymag.com/thecut/2017/04/what-cannabidiol-oil-did-for-me.html
• A Mother With Stage 4 Colon Cancer: How Marijuana Helped (news–2017) https://thefreshtoast.com/cannabis/a-mother-with-stage-4-colon-cancer-how-marijuana-helped/#sthash.wTX7QKIa.dpuf
• Natural chemical helps brain adapt to stress (news–2017) https://www.sciencedaily.com/releases/2017/03/170329140945.htm
• How marijuana edibles keeps this guy focused and working (news–2017) http://www.salon.com/2017/05/07/how-marijuana-edibles-keeps-this-guy-focused-and-working_partner-2/
• Cannabis is an Effective Treatment for PTSD (news–2017) https://www.marijuanatimes.org/cannabis-is-an-effective-treatment-for-ptsd/
• Changes in the Brain Endocannabinoid System in Rat Models of Depression. (Poland, full, 2017) https://link.springer.com/article/10.1007/s12640-017-9708-y 
• Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury. (USA, full, 2017) https://www.frontiersin.org/articles/10.3389/fphar.2017.00095/full 
• Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. (USA, full, 2017) https://www.nature.com/articles/ncomms14782 
• Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. (Brazil/ Spain/ USA, full, 2017) https://www.frontiersin.org/articles/10.3389/fphar.2017.00269/full 
• Residential Mobility, Transience, Depression, and Marijuana Use Initiation Among Adolescents and Young Adults. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457171/ 
• Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice. (Spain, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486147/ 
• Cannabis as a substitute for prescription drugs - a cross-sectional study. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422566/ 
• Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562300/ 
• Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles. (China, full, 2017) https://www.karger.com/Article/FullText/480001 
• An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. (Germany, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/ 
• Effects of cannabis use and subclinical depression on the P3 event-related potential in an emotion processing task. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371467/ 
• Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression. (Republic of Korea, full, 2017) https://www.sciencedirect.com/science/article/pii/S221112471730863X 
• Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. (USA/ Japan/ Brazil, full, 2017) https://www.nature.com/articles/s41598-017-17796-y 
• Schizophrenia and depression, two poles of endocannabinoid system deregulation. (Spain, full, 2017) https://www.nature.com/articles/s41398-017-0029-y 
• Cannabinoid Modulation of the Stressed Hippocampus. (Brazil, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/ 
• Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed cannabinoids. (USA, full, 2017) https://casereports.bmj.com/content/2017/bcr-2017-222059.long 
• Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515287/ 
• Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633491/ 
• Mechanisms Underlying Sex Differences in Cannabis Use. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828236/ 
• Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572754/ 
• Nucleus Accumbens Functional Connectivity at Age 20 is Associated with Trajectory of Adolescent Cannabis Use and Predicts Psychosocial Functioning in Young Adulthood. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633503/ 
• Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661891/ 
• Adolescent peer networks and the moderating role of depressive symptoms on developmental trajectories of cannabis use. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614846/ 
• Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids imbalance. (France, full, 2017) https://www.jneurosci.org/content/37/29/6851.full 
• Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls. (Canada, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603819/ 
• Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. (USA/ Canada/ Italy, full, 2017) https://www.nature.com/articles/npp2017162 
• The effects of synthetic cannabinoids on executive function. (Israel/ Hungary, link to PDF, 2017) https://www.researchgate.net/publication/313320166_The_effects_of_synthetic_cannabinoids_on_executive_function 
• Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels. (USA, link to PDF, 2017) https://www.researchgate.net/publication/315436386_Endocannabinoid_and_Mood_Responses_to_Exercise_in_Adults_with_Varying_Activity_Levels 
• Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats. (Italy/ Hungary, link to PDF, 2017) https://www.researchgate.net/publication/317858765_Emotional_disorders_induced_by_Hemopressin_and_RVD-hemopressina_administration_in_rats 
• Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. (Italy, link to PDF, 2017) https://www.researchgate.net/publication/319590700_Antibiotic-induced_microbiota_perturbation_causes_gut_endocannabinoidome_changes_hippocampal_neuroglial_reorganization_and_depression_in_mice 
• Cannabis use and mental health-related quality of life among individuals with depressive disorders. (Israel/ Germany/ Canada, download, 2017) https://isiarticles.com/bundles/Article/pre/pdf/60067.pdf 
• Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms. (Australia/ Netherlands/ Spain/ UK, click “uow” for download, 2017) https://ro.uow.edu.au/cgi/viewcontent.cgi?article=4143&context=sspapers 
• Is cannabis treatment for anxiety, mood, and related disorders ready for prime time? (Canada, click “therocus” for download, 2017) https://onlinelibrary.wiley.com/doi/abs/10.1002/da.22664 
• User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate. (Australia/ UK, full, 2017)  https://discovery.ucl.ac.uk/id/eprint/1563617/1/Freeman_Chan%20et%20al.%202017.pdf 
• Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress. (Iran, full, 2017) http://eprints.skums.ac.ir/169/1/1-s2.0-S0361923016303100-main.pdf 
• Role of the endocannabinoid system in the formation and development of depression. (China, click “ingentaconnectcom” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Role+of+the+endocannabinoid+system+in+the+formation+and+development+of+depression.%22&btnG 
• Role of cannabinoid receptor 1-mediated synaptic plasticity in neuropathic pain and associated depression. (China, abstract, 2017) https://pubmed.ncbi.nlm.nih.gov/28364110/ 
• Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders. (USA, abstract, 2017) https://jamanetwork.com/journals/jama/article-abstract/2610319 
• FAAH Inhibition Produces Antidepressant-like efforts of Mice to Acute Stress via Synaptic Long-term Depression. (Canada/ China, abstract, 2017) https://www.semanticscholar.org/paper/FAAH-inhibition-produces-antidepressant-like-of-to-Wang-Zhang/96fbdee29bffa8d030b4d8f8e386d4b059ba69c4 
• Associations between substance use disorders and suicide or suicide attempts in people with mental illness: A Danish nationwide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder. (Denmark, abstract, 2017) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.13788 
• Cannabinoids as therapeutic for PTSD. (USA, abstract, 2017) https://www.sciencedirect.com/science/article/pii/S2352250X16302342 
• Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study. (Germany, abstract, 2017) https://www.semanticscholar.org/paper/Electroconvulsive-therapy-enhances-endocannabinoids-Kranaster-Hoyer/54805dc0791bf9c61590fdc9dc30b9a2f7b3ad96 
• Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis. (USA/ Canada, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0278584616302470?via%3Dihub 
• Properties of the corticostriatal long term depression induced by medial prefrontal cortex high frequency stimulation in vivo. (Argentina, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0028390817301971 
• Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum. (Italy, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0969996117301717?via%3Dihub 
• CHANGES IN THE CANNABINOIDS RECEPTORS IN RATS FOLLOWING TREATMENT WITH ANTIDEPRESSANTS. (Poland, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0161813X17301717 
• Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. (Israel, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0165032716320018?via%3Dihub 
• 2016
• Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
• Treating Depression in Alcoholics (news & abst–2016) http://neurosciencenews.com/alcoholism-depression-psychology-3541/
• Cannabis Compares Favorably to Conventional PTSD Treatments (news–2016) http://www.prweb.com/releases/2016/03/prweb13244763.htm
• Smoking cannabis DOESN’T cause clinical anxiety or depression, study finds (news–2016) http://www.dailymail.co.uk/news/article-3456326/Smoking-cannabis-DOESN-T-cause-clinical-anxietydepression.html#ixzz45lywpZ11
• An elderly couple found help for a brain injury through marijuana – then police found 20 pot plants growing at their home (news–2016) http://www.nashvillescene.com/nashville/an-elderly-couple-found-help-for-a-brain-injury-throughmarijuana-andmdash-then-police-found-20-pot-plants-growing-at-their-home/Content?oid=6798313
• Marijuana Appears to Benefit Mental Health: Study (news–2016) http://time.com/4573129/marijuana-cannabis-mental-health/
• Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. (USA, full, 2016) https://elifesciences.org/articles/14137 
• Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor. (Japan, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942073/ 
• Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. (Israel/ Brazil, full, 2016) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158779 
• Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress. (France, full, 2016) https://www.cell.com/cell-reports/fulltext/S2211-1247(16)30851-8 
• The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado. (USA, full, 2016) https://peerj.com/articles/2782/ 
• Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive Behavior during Forced Abstinence from Alcohol Drinking. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908652/ 
• Lipids in psychiatric disorders and preventive medicine. (Germany/ USA, full, 2016) https://www.sciencedirect.com/science/article/pii/S0149763415303353 
• The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833569/ 
• Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids. (USA/ Canada, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/ 
• Endocannabinoid system: Role in depression, reward and pain control (Review). (China, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042796/ 
• Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803661/ 
• Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289074/ 
• Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function. (USA, full, 2016) https://www.frontiersin.org/articles/10.3389/fphar.2016.00355/full 
• Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818147/ 
• Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915997/ 
• The genetic basis of the comorbidity between cannabis use and major depression. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148647/ 
• Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma. (Hungary, full, 2016) https://www.sciencedirect.com/science/article/pii/S0924977X16000778 
• Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus. (China, full, 2016) https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.13613 
• Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological - cardiac comorbidity? (Italy/ Australia/ USA, link to PDF, 2016) https://www.researchgate.net/publication/301734639_Pharmacological_inhibition_of_FAAH_activity_in_rodents_A_promising_pharmacological_approach_for_psychological-cardiac_comorbidity 
• The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders. (Iran, link to PDF, 2016) https://www.researchgate.net/publication/291185238_The_endocannabinoid_system_and_NGF_are_involved_in_the_mechanism_of_action_of_resveratrol_A_multi-target_nutraceutical_with_therapeutic_potential_in_neuropsychiatric_disorders 
• Cannabidiol, neuroprotection and neuropsychiatric disorders. (Brazil, link to download, 2016) https://static1.squarespace.com/static/57faf399cd0f68a69b4c670c/t/5839e5e4e58c622c253519e9/1480189413826/Cannabidiol%2C+neuroprotection+and+neuropsychiatric+disorders.pdf 
• Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review. (Canada, link to download, 2016) https://www.eurekaselect.com/138787/article 
• Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. (Brazil, click “researchgate” for download, 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabidiol+reduces+neuroinflammation+and+promotes+neuroplasticity+and+functional+recovery+after+brain+ischemia%22&btnG 
• Medical cannabis and mental health: A guided systematic review. (Canada/ USA, click “ubcca” for download, 2016) http://blogs.ubc.ca/walshlab/files/2015/06/Review-Article.pdf 
• The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models. (USA, 1st page, 2016) https://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00532-6/fulltext 
• Role of hypothalamic cannabinoid receptors in post-stroke depression in rats. (China, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0361923016300065 
• Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex – possible involvement of 5-HT1A and CB1 receptors. (Brazil, abstract, 2016) https://www.sciencedirect.com/science/article/pii/S0166432816300298 
• Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. (Brazil, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0924977X1630164X 
• Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. (USA, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0892036216300101?via%3Dihub 
• Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. (Denmark/Norway, abstract, 2016) https://www.semanticscholar.org/paper/Gender-Differences-in-Associations-Between-Disorder-Ottosen-Petersen/86e5674b13ccbccc152be48f60a96762f9d50c24 
• Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers. (Brazil, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0031938416300269 
• Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy. (USA, abstract, 2016) https://www.redjournal.org/article/S0360-3016(14)02729-1/fulltext 
• Prohedonic Effect of Cannabidiol in a Rat Model of Depression. (Israel/ USA, abstract, 2016) https://www.semanticscholar.org/paper/Prohedonic-Effect-of-Cannabidiol-in-a-Rat-Model-of-Shoval-Shbiro/c0e3c58433e19601581b85347d747a449f687844 
• Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents. (Australia/ UK, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0376871616301806 
• Contribution of health motive to cannabis use among high-school students. (France, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316302829 
• Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex. (Germany, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0028390816304580 
• Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors. (France/ Italy, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0028390816304579 
• Targeting the Endocannabinoid System in Psychiatric Illness. (Canada, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27811555/ 
• Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences. (Spain, abstract, 2016) https://www.sciencedirect.com/science/article/pii/S0091305716302465 
• Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis. (Canada, abstract, 2016) https://www.msard-journal.com/article/S2211-0348(16)30171-7/fulltext 
• A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats. (Denmark/ Brazil, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27938441/ 

• Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. (Israel, Germany, Canada, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0165178116311878 

• Signaling pathways to and from the hypophysial pars tuberalis, an important center for the control of seasonal rhythms. (Germany, abstract, 2016) https://www.sciencedirect.com/science/article/pii/S0016648017302320?via%3Dihub 
• 2015
• Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015) http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
• New Study Finds Marijuana To Be Effective Against Depression (news–2015) http://www.huffingtonpost.com/2015/02/06/marijauna-depression_n_6622126.html
• Here’s What Marijuana Does to Your Stress (news–2015) http://www.attn.com/stories/855/marijuana-depression-research-mental-health
• 5 Prescription Drugs That Could Literally Replaced by Marijuana (news–2015) http://blogs.naturalnews.com/5-prescription-drugs-literally-replaced-marijuana/
• Teen marijuana use not linked to later depression, lung cancer, other health problems, study finds (news–2015)  http://www.sciencedaily.com/releases/2015/08/150804093718.htm
  Former U.S. Marine starts campaign to raise awareness of overmedication of veterans (news–2015) http://globalnews.ca/news/2065096/former-u-s-marine-starts-campaign-to-raise-awareness-of-overmedication-of-veterans/
• Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. (USA/ China, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517601/ 
• High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity. (Ireland, full, 2015) https://academic.oup.com/ijnp/article/19/3/pyv095/2910048 
• Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression? (UK, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828487/ 
• Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586320/ 
• Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/ 
• Mechanisms of stress in the brain. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933289/ 
• Cannabis use, depression and anxiety: A 3-year prospective population-based study. (Sweden, full, 2015) https://www.sciencedirect.com/science/article/pii/S0165032715310302 
• Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats. (USA/ Italy, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793117/ 
• Habenular CB1 Receptors Control the Expression of Aversive Memories. (France/ China, full, 2015) https://www.cell.com/neuron/fulltext/S0896-6273(15)00729-1 
• Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724469/ 
• Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants. (Japan, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759315/ 
• Maternal age and trajectories of cannabis use. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633363/ 
• Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats. (Italy, link to download, 2015) https://www.academia.edu/22102103/Antidepressant_like_activity_and_cardioprotective_effects_of_fatty_acid_amide_hydrolase_inhibitor_URB694_in_socially_stressed_Wistar_Kyoto_rats
• Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5- HT/glutamate neurotransmission: role of 5-HT1A receptors. (Spain, link to download, 2015) https://www.alchimiaweb.com/blogfr/wp-content/uploads/2016/06/Cannabidiol-induces-rapid-acting-antidepressant-like-effects-and-enhances-cortical-5-HT-glutamate-neurotransmission-Role-of-5-HT1A-receptors-LINGE-NP-2016.pdf 
• For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. (Ireland, click “academia” for download, 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=For+whom+the+endocannabinoid+tolls%3A+Modulation+of+innate+immune+function+and+implications+for+psychiatric+disorders.&btnG 
• Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair. (China, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S0304394015002049 
• Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression. (China, abstract, 2015) https://www.sciencedirect.com/science/article/pii/S0091305715000283 
• The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs-A practical view. (Sweden, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/25791296/ 
• Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system. (Poland, abstract, 2015) https://www.sciencedirect.com/science/article/pii/S0166432815000789?via%3Dihub 
• Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress. (Republic of Korea/ China, link to PDF, 2015) https://www.researchgate.net/publication/276440137_Antidepressant-like_effects_of_oleoylethanolamide_in_a_mouse_model_of_chronic_unpredictable_mild_stress 
• Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption. (Israel, abstract, 2015) https://www.safetylit.org/citations/index.php?fuseaction=citations.viewdetails&citationIds%5b%5d=citjournalarticle_483021_13 
• The endocannabinoid system role in the pathogenesis of obesity and depression. (Poland, abstract in English & Polish, 2015) http://medpress.com.pl/pubmed.php?article=22961 
• A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients. (France, abstract, 2015) https://www.semanticscholar.org/paper/A-cannabinoid-receptor-1-polymorphism-is-protective-Icick-Peoc%E2%80%99h/9b80448d11e7fa112c7f5ffab2ed1a474e76df79 
• Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice. (Iran, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/26609670/ 
• The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus. (Canada/ Italy, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S0924977X15004101?via%3Dihub 
• Mediating processes between stress and problematic marijuana use. (USA, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S0306460315000167   
• 2014
• Activating cannabinoid brain receptors could replace marijuana for anxiety treatment (news–2014) http://www.medicalnewstoday.com/articles/286482.php
• Natural ‘high’ could avoid chronic marijuana use, Vanderbilt study finds (news–2014) http://news.vanderbilt.edu/2014/12/natural-high-could-avoid-chronic-marijuana-use-vanderbilt-study-finds/
• 2013
• Study: THC Increases Brain Activity In Response To Positive Stimuli (news–2013) http://blog.norml.org/2013/08/27/study-thc-increases-brain-activity-in-response-to-positive-stimuli/
• This bud’s for you: Marijuana identified as a buffer against loneliness, study suggests (news–2013) http://o.canada.com/life/marijuana-can-act-as-buffer-against-loneliness-study-suggests/
• Psychological Benefits Of Marijuana Usage (news–2013)  http://mentalhealthdaily.com/2013/03/05/psychological-benefits-of-marijuana-usage/
• 2012
• Smoking Cannabis Increases Risk of Depression in the Case of Genetic Vulnerability, Study Finds (news–2012) http://www.sciencedaily.com/releases/2011/10/111010074853.htm
• How Smoking Marijuana may Help Women to Fight Nasty Symptoms of Menopause? (news–2012) http://menopause-aid.blogspot.com/2012/11/how-smoking-marijuana-may-help-women-to.html    
• 2011
• Deficiency of Dietary Omega-3 May Explain Depressive Behaviors (news-2011) http://www.thefreelibrary.com/Deficiency+of+Dietary+Omega-3+May+Explain+Depressive+Behaviors.-a0248155576
• What An Expectant Mother Eats Affects Children’s Psychology in Later Life (news–2011) http://nanopatentsandinnovations.blogspot.com/2011/01/what-expectant-mother-eats-affects.html
• A Brain Wrought Without Omega-3 (news–2011) http://www.alzforum.org/news/research-news/brain-wrought-without-omega-3
• Natural Herbs That Increase Serotonin (news–2011) http://www.livestrong.com/article/53343-natural-herbs-increase-serotonin/